Search results
The Direct to Cancer manuscript submission pathway offers an accelerated review process for potentially practice-changing/informing manuscripts that have been rejected after peer review by high-impact general medicine or oncology journals for reasons of scope or priority.
Submission Checklist. Please: Read the Aims & Scope to gain an overview and assess if your manuscript is suitable for this journal; Use the Microsoft Word template or LaTeX template or Free Format Submission to prepare your manuscript;
JNCI: The Journal of the National Cancer Institute publishes manuscripts that describe novel findings of significance in cancer research with a particular focus on clinical, epidemiologic, behavioral, and health outcomes studies. Submission of reviews, minireviews, and commentaries are welcome (see Manuscript type below for specific requirements).
How to submit. Synopses and manuscripts must be submitted electronically through our online submission system, using the link and instructions provided by the editor.
Make sure you are submitting to the most suitable journal - Aims and scope. Understand the costs and funding options - Fees and funding. Make sure your manuscript is accurate and readable - Language editing services. Understand the copyright agreement - Copyright.
Cancer Medicine is an open access, interdisciplinary oncology journal providing rapid publication of research from global biomedical researchers across the cancer sciences. Indexed in Medline and Web of Science, we cover the breadth of oncology: clinical cancer research, cancer biology, cancer prevention, and bioinformatics.
Trained on 300,000+ research manuscripts from more than 400+ areas of study and over 2000 field-specific topics the tool will deliver fast, highly accurate English language improvements. Your paper will be digitally edited and returned to you within approximately 10 minutes.
